Abstract
Pulmonary infection, often insidious, is frequent in primary immunodeficiency (PID) and acquired immunodeficiency. Pulmonary complications are serious obstacles to success of haematopoietic SCT (HSCT) for these conditions. Bronchoalveolar lavage (BAL) permits identification of lower respiratory tract pathogens that may direct specific treatment and influence prognosis. There are no reports about the utility of pre-HSCT BAL for immunodeficient patients. We prospectively studied the value of ‘routine’ BAL before commencing transplantation in patients undergoing HSCT for severe immunological disease. Routine non-bronchoscopic BAL was performed under general anaesthetic, a few days before commencing pre-HSCT cytoreductive chemotherapy. Patients were categorized as symptomatic or asymptomatic with respect to pulmonary disease or infection. Samples were sent for microbiological processing. Complications arising from the procedure, pathogens isolated and treatments instituted were recorded. Results were available from 69/75 patients transplanted during the study period; 26 (38%) had pathogens identified (six asymptomatic patients), 10 (14.5%) developed complications post-procedure (two asymptomatic patients)—all recovered, 21 had management changes. There was no statistically significant difference in the number of positive isolates from severe combined or other immunodeficient patients, or of symptomatic or asymptomatic patients. Routine non-bronchoscopic BAL is safe in immunodeficient patients about to undergo HSCT, and leads to management changes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al, European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003; 361: 553–560.
De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318–1326.
Berrington JE, Flood TJ, Abinun M, Galloway A, Cant AJ . Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency. Arch Dis Child 2000; 82: 144–147.
Kroe DM, Kirsch CM, Jensen WA . Diagnostic strategies for Pneumocystis carinii pneumonia. Semin Respir Infect 1997; 12: 70–78.
Whittle AT, Davis M, Johnson PR, Leonard RC, Greening AP . The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia. Bone Marrow Transplant 1999; 24: 63–67.
Efrati O, Gonik U, Bielorai B, Modan-Moses D, Neumann Y, Szeinberg A et al. Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer. Pediatr Blood Cancer 2006; 48: 324–329.
Park JR, Fogarty S, Brogan TV . Clinical utility of bronchoalveolar lavage in pediatric cancer patients. Med Pediatr Oncol 2002; 39: 175–180.
Vega-Briceno LE, Holmgren NL, Bertrand P, Rodriguez JI, Barriga F, Contreras I et al. Utility of bronchoalveolar lavage in immunocompromised children: diagnostic yield and complications. Arch Bronconeumol 2004; 40: 570–574.
Bissinger AL, Einsele H, Hamprecht K, Schumacher U, Kandolf R, Loeffler J et al. Infectious pulmonary complications after stem cell transplantation or chemotherapy: diagnostic yield of bronchoalveolar lavage. Diagn Microbiol Infect Dis 2005; 52: 275–280.
Hohenthal U, Itala M, Salonen J, Sipila J, Rantakokko-Jalava K, Meurman O et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy—value of new microbiological methods. Eur J Haematol 2005; 74: 203–211.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slatter, M., Rogerson, E., Taylor, C. et al. Value of bronchoalveolar lavage before haematopoietic stem cell transplantation for primary immunodeficiency or autoimmune diseases. Bone Marrow Transplant 40, 529–533 (2007). https://doi.org/10.1038/sj.bmt.1705776
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705776